Pharmaceutical Exports

37 posts

Active Pharmaceutical Ingredients Manufacturing in Pakistan – Asrar Qureshi’s Blog Post #1207

Asrar Qureshi’s blog highlights Pakistan’s critical API import dependence and the necessity for local API manufacturing. With over 85% APIs imported, this reliance poses health and economic risks. Establishing domestic plants is essential for health security, export competitiveness, and economic resilience. Past missed opportunities emphasize the urgency for investment and strategic initiatives.
Share
View Post
  • 5 min

Why Pakistan’s Pharmaceutical Exports Lag Behind and How to Fix It– Asrar Qureshi’s Blog Post #1124

Pakistan’s pharmaceutical exports are notably low despite having a robust industry, with challenges including inadequate investment in facilities, lack of international certifications, inconsistent compliance with quality standards, and insufficient market intelligence. Strategic reforms, including regulatory improvements and investment in workforce development, are essential for enhancing exports and achieving global competitiveness.
Share
View Post
  • 6 min

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share